Ascentage Pharma Group International

Common Name
Ascentage Pharma
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
567
Ticker
6855
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Ascentage Pharma Group International is a biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies for cancer, hepatitis, and age-related dise...

Ascentage Pharma's Climate Target Data Preview

As of 2023, Ascentage Pharma has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Ascentage Pharma ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2040

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Ascentage Pharma's Greenhouse Gas Emissions Pathways

As of 2023, Ascentage Pharma has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Want Full Access to Ascentage Pharma's Climate Targets Dataset?
Sign Up